Tech Company Financing Transactions
Cambria Pharmaceuticals Funding Round
Cambria Pharmaceuticals, based in Woburn, scored $5.4 million in funding from Biogen Idec and Commission Junction.
Transaction Overview
Company Name
Announced On
4/22/2008
Transaction Type
Venture Equity
Amount
$5,400,000
Round
Series A
Investors
Proceeds Purpose
This investment will be used, along with a comparable amount of venture philanthropy funding that we have previously obtained, to advance our lead program in ALS, as well as drug discovery efforts for other serious neurological disorders," stated Leo Liu, M.D., President and CEO.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8A Henshaw St.
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
The Company exploits recent discoveries in the genetic basis of these disorders to engineer novel disease models and identify first-in-class, disease-modifying compounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leo Liu
Browse more venture capital transactions:
Prev: 4/22/2008: Resolvyx Pharmaceuticals venture capital transaction
Next: 4/22/2008: Celsense venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs